Transitional Cell Carcinoma of the Renal Pelvis and Ureter
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Renal Pelvis and Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]
Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial can…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating gemcitabine, paclitaxel, and cisplatin for advanced urothelial cancer (bladder cancer and transitional cell cancer …
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
This clinical trial update reports on biomarker studies in patients with kidney cancer or urothelial cancers and in healthy participants.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract [Phase 2]
Phase 2 SWOG trial of gemcitabine and paclitaxel in advanced or recurrent urinary tract cancers (bladder cancer, transitional cell carcinoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with filgrastim for locally recurrent or advanced urothelial cancer, including bladder can…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [Phase 2]
Phase 2 study of fluorouracil in recurrent or metastatic bladder cancer, including transitional cell carcinoma of the renal pelvis and urete…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Oxaliplatin in Treating Patients With Metastatic Bladder Cancer [Phase 2]
Phase 2 clinical trial update showing oxaliplatin used for metastatic bladder cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial evaluating pazopanib hydrochloride in patients with metastatic bladder cancer, urethral cancer, or transitional cel…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating Sunitinib malate in patients with locally recurrent, locally advanced, unresectable, or metastatic urinary tract ca…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating combination chemotherapy after surgery for bladder cancer an…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating a combination chemotherapy regimen for metastatic or locally advanced bladder cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer [Phase 1]
A completed Phase 1 clinical trial evaluating a combination chemotherapy regimen for advanced bladder cancer and transitional cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating combination chemotherapy for transitional cell cancers of the urothelium has completed, includin…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial of Romidepsin (FR901228) in advanced urothelial cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial of Nitrocamptothecin for metastatic cancer of the urinary tract has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
A Phase 2 clinical trial evaluating SCH 66336 (lonafarnib) in combination with gemcitabine for advanced cancers of the urinary tract has com…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer [Phase 2]
This Phase 2 trial evaluated sunitinib as second-line therapy for locally advanced or metastatic transitional cell cancer of the bladder and…